Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.06 - $15.0 $5,472 - $6,285
419 Added 15.01%
3,211 $47,000
Q4 2023

Feb 09, 2024

BUY
$12.02 - $13.41 $7,440 - $8,300
619 Added 28.49%
2,792 $37,000
Q3 2023

Nov 13, 2023

SELL
$11.6 - $12.52 $26,366 - $28,457
-2,273 Reduced 51.12%
2,173 $26,000
Q2 2023

Aug 15, 2023

BUY
$12.02 - $13.07 $51,397 - $55,887
4,276 Added 2515.29%
4,446 $54,000
Q1 2023

May 12, 2023

BUY
$11.35 - $12.32 $22 - $24
2 Added 1.19%
170 $2,000
Q4 2022

Feb 13, 2023

SELL
$3.68 - $12.51 $261 - $888
-71 Reduced 29.71%
168 $1,000
Q3 2022

Nov 14, 2022

BUY
$3.7 - $6.06 $432 - $709
117 Added 95.9%
239 $1,000
Q2 2022

Aug 12, 2022

BUY
$4.89 - $7.13 $29 - $42
6 Added 5.17%
122 $0
Q3 2021

Nov 15, 2021

SELL
$4.3 - $6.39 $86 - $127
-20 Reduced 14.71%
116 $0
Q2 2021

Aug 16, 2021

SELL
$6.04 - $7.77 $6 - $7
-1 Reduced 0.73%
136 $1,000
Q4 2020

Feb 09, 2021

BUY
$3.69 - $8.31 $18 - $41
5 Added 3.79%
137 $1,000
Q3 2020

Nov 05, 2020

BUY
$3.1 - $4.3 $12 - $17
4 Added 3.13%
132 $0
Q1 2020

May 14, 2020

BUY
$1.63 - $3.58 $208 - $458
128 New
128 $0

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.